Screener
Silexion Therapeutics SLXN Q1 2026 earnings
Reported May 15, 2026 · Before market open
EPS-$0.85Beat by $0.44
EPS estimate-$1.29
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$9.10
Versus estimates
Diluted EPS
FAQ
- When did Silexion Therapeutics report Q1 2026 earnings?
- Silexion Therapeutics (SLXN) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Silexion Therapeutics's Q1 2026 revenue and EPS?
- Silexion Therapeutics reported eps of $-0.85 for Q1 2026.
- Did Silexion Therapeutics beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-1.29 by $0.44.
- How did Silexion Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 78.2% from $-3.90.
- Where can I find Silexion Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001178913-26-002624) and the 10-Q periodic report (0001178913-26-002744) directly on SEC EDGAR. The filing index links above go to sec.gov.
